| Date Filed | Type | Description |
| 01/29/2021 |
4
| McMahon Gerald PhD (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 181,470 options to buy
@ $18.66, valued at
$3.4M
|
|
| 02/04/2020 |
4
| McMahon Gerald PhD (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 165,210 options to buy
@ $13.29, valued at
$2.2M
|
|
| 09/06/2019 |
4
| McMahon Gerald PhD (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Exercised 169,462 options to buy
@ $0.6, valued at
$101.7k
|
|
| 05/16/2019 |
4
| McMahon Gerald PhD (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $10.1573, valued at
$10.2k
|
|
| 05/10/2019 |
4
| McMahon Gerald PhD (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $10.5587, valued at
$10.6k
|
|
| 05/07/2019 |
4
| McMahon Gerald PhD (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $10.53, valued at
$10.5k
|
|
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/04/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,824 shares
@ $0.2986, valued at
$843.2 |
|
| 11/02/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,888 shares
@ $0.3145, valued at
$908.3 |
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,813 shares
@ $0.502, valued at
$1.4k
|
|
| 08/02/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,813 shares
@ $0.465, valued at
$1.3k
|
|
| 07/03/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,813 shares
@ $0.5036, valued at
$1.4k
|
|
| 06/15/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 67,000 options to buy
@ $0.6011, valued at
$40.3k
|
|
| 06/04/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,813 shares
@ $0.5802, valued at
$1.6k
|
|
| 05/02/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,813 shares
@ $0.74, valued at
$2.1k
|
|
| 04/03/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,379 shares
@ $2.33, valued at
$7.9k
|
|
| 03/02/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,415 shares
@ $2.25, valued at
$7.7k
|
|
| 02/02/2018 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,415 shares
@ $2.76, valued at
$9.4k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2017 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,212 shares
@ $3, valued at
$9.6k
|
|
| 11/02/2017 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,212 shares
@ $2.44, valued at
$7.8k
|
|
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2013 |
4
| McMahon Gerald PhD (Director) has filed a Form 4 on OXIGENE INC|
Txns:
| Granted 3,773 shares
@ $0 |
|
|